Reimbursement Scheme Jardiance® (empagliflozin)10 mg for patients with HFpEF (Ejection fraction>40%)
The health insurer does not yet fully reimburse Jardiance (Empagliflozin)® 10 mg for the treatment of HFpEF (Ejection fraction...
Extension to TerugBetaalRegeling Acecort®
Recently also Acecort® 2 and 3 mg tablets have been registered. The health insurer will not reimburse the cost in full. The...
Renewal reimbursement scheme Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine HCI) 5 mg
The Reimbursement Solution TerugBetaalRegeling (TBR) of Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine...
Termination TerugBetaalRegeling Tecfidera®
As of December 1, 2021, a Personal Contribution for Tecfidera is no longer required. Health insurers will once again fully...
Termination TerugBetaalRegeling Fragmin®2500
From January 1st 2022 onwards, the reimbursement scheme for FRAGMIN (dalteparine)2500 INJVLST 12.500IE/ML WWSP 0,2ML will be...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine